As the need for remote health monitoring intensifies during the COVID-19 epidemic, Sensyne Health are developing and deploying products that enable patient groups to record their health information and be safely managed at home, clinicians to deliver continued contact and care, and healthcare organisations such as the NHS to reduce pressure on their resources. Data generated from these products contributes to medical research aimed at predicting, diagnosing, treating and preventing a variety of conditions including COVID-19 infection.
Our business aims to have a double bottom line, providing an attractive return to our shareholders and making a positive social impact, improving health and generating wealth that we share with our NHS Trust partners.Find out more about us
It builds on Sensyne Health's expertise in developing remote patient monitoring systems and is available to anyone in the UK who is 18 years of age or older.
Our response to COVID-19 and how we built on our experience and knowledge of remote patient monitoring to make a difference.
Our Strategic Research Agreements (SRAs) with NHS Trusts allow us access to the unique, longitudinal anonymised patient datasets that only the NHS can provide.Strategic Research Agreements
Our Software Products team develop clinically validated digital health products that create clinician and patient benefit while gathering curated data.
By applying Clinical AI methods to anonymised NHS patient data, we help life sciences companies develop new treatments faster and at a lower cost to address unmet patient needs.